 |
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
|
|
|
|
Stock data
| Last Trade | 61.57 | Trade Time | 5/17/2013 |
| Change |  -0.13
|
Volume (thou) | 1792.7 |
| %Change | -.21% | Last Trade Size | |
| Open | 61.73 | Bid | 61.56 |
| Today's High | 62.69 | Ask | 61.6 |
| Today's Low | 58.83 | Size Bid/Ask | 0 x0 |
Fundamental Data |
|||
| Market Cap (mil) | 1774385.83 | 52 Week High | 63.72 |
| Shrs Outstanding (thou) | 28819000 | 52 Week Low | 12.87 |
| EPS | -2.73 | PE Ratio | .00 |
| Volatility | Yield | .00 | |
| Dividend Freq. | 0 | Ex-Dividend Date | 12:00:00 AM |
| Dividend Amount | 0 | Exchange | NASDAQ GS |
| Delayed quotes powered by S&P comstock. All stock quotes are delayed by 20 minutes and are believed to be accurate but are not warranted or guaranteed by MENAFN.com | |||
Related News
 |
May 06, 2013 | Aegerion Pharmaceuticals Inc provides stock options at exercise price of USD43.65 per share, M2 |
|
May 03, 2013 | Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program, GlobeNewswire |
|
May 03, 2013 | Aegerion Pharmaceuticals Announces Presentation at the Bank of America Merrill Lynch 2013 Healthcare Conference, GlobeNewswire |
|
Apr 30, 2013 | Aegerion Pharmaceuticals Announces First-Quarter 2013 Financial Results, GlobeNewswire |
|
Apr 30, 2013 | Aegerion Pharmaceuticals Inc names Anne M. VanLent to board, M2 |
|
Apr 29, 2013 | Anne VanLent Appointed to Aegerion Pharmaceuticals' Board of Directors, GlobeNewswire |
|
Apr 25, 2013 | Aegerion Pharmaceuticals Announces Presentation at the Needham Healthcare Conference, GlobeNewswire |
 more... |
||
